1. Home
  2. PTHL vs NUKK Comparison

PTHL vs NUKK Comparison

Compare PTHL & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • NUKK
  • Stock Information
  • Founded
  • PTHL 1998
  • NUKK 2013
  • Country
  • PTHL China
  • NUKK United States
  • Employees
  • PTHL N/A
  • NUKK N/A
  • Industry
  • PTHL
  • NUKK Blank Checks
  • Sector
  • PTHL
  • NUKK Finance
  • Exchange
  • PTHL Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • PTHL 85.4M
  • NUKK 77.4M
  • IPO Year
  • PTHL 2024
  • NUKK N/A
  • Fundamental
  • Price
  • PTHL $17.85
  • NUKK $10.93
  • Analyst Decision
  • PTHL
  • NUKK
  • Analyst Count
  • PTHL 0
  • NUKK 0
  • Target Price
  • PTHL N/A
  • NUKK N/A
  • AVG Volume (30 Days)
  • PTHL 1.1M
  • NUKK 594.9K
  • Earning Date
  • PTHL 02-11-2025
  • NUKK 07-07-2025
  • Dividend Yield
  • PTHL N/A
  • NUKK N/A
  • EPS Growth
  • PTHL N/A
  • NUKK N/A
  • EPS
  • PTHL N/A
  • NUKK N/A
  • Revenue
  • PTHL $448,196.00
  • NUKK N/A
  • Revenue This Year
  • PTHL N/A
  • NUKK N/A
  • Revenue Next Year
  • PTHL N/A
  • NUKK N/A
  • P/E Ratio
  • PTHL N/A
  • NUKK N/A
  • Revenue Growth
  • PTHL N/A
  • NUKK N/A
  • 52 Week Low
  • PTHL $1.32
  • NUKK $1.30
  • 52 Week High
  • PTHL $22.34
  • NUKK $78.32
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • NUKK 41.99
  • Support Level
  • PTHL N/A
  • NUKK $9.90
  • Resistance Level
  • PTHL N/A
  • NUKK $11.46
  • Average True Range (ATR)
  • PTHL 0.00
  • NUKK 1.33
  • MACD
  • PTHL 0.00
  • NUKK -0.10
  • Stochastic Oscillator
  • PTHL 0.00
  • NUKK 13.96

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: